STRS Ohio’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $607K | Sell |
74,600
-31,400
| -30% | -$285K | ﹤0.01% | 942 |
|
|
2025
Q4 | $712K | Buy |
106,000
+19,400
| +22% | +$146K | ﹤0.01% | 836 |
|
|
2025
Q3 | $751K | Sell |
86,600
-13,500
| -13% | -$105K | ﹤0.01% | 799 |
|
|
2025
Q2 | $631K | Buy |
100,100
+74,000
| +284% | +$490K | ﹤0.01% | 1108 |
|
|
2025
Q1 | $167K | Hold |
26,100
| – | – | ﹤0.01% | 1557 |
|
|
2024
Q4 | $210K | Hold |
26,100
| – | – | ﹤0.01% | 1490 |
|
|
2024
Q3 | $330K | Hold |
26,100
| – | – | ﹤0.01% | 1419 |
|
|
2024
Q2 | $330K | Sell |
26,100
-85,200
| -77% | -$857K | ﹤0.01% | 1409 |
|
|
2024
Q1 | $532K | Buy |
111,300
+11,100
| +11% | +$51.5K | ﹤0.01% | 1217 |
|
|
2023
Q4 | $480K | Buy |
100,200
+19,700
| +24% | +$121K | ﹤0.01% | 1299 |
|
|
2023
Q3 | $582K | Sell |
80,500
-4,000
| -5% | -$32K | ﹤0.01% | 1160 |
|
|
2023
Q2 | $627K | Buy |
+84,500
| New | +$665K | ﹤0.01% | 1148 |
|
|
2022
Q2 | – | Sell |
-4,300
| Closed | -$316K | – | 2205 |
|
|
2022
Q1 | $316K | Buy |
+4,300
| New | +$383K | ﹤0.01% | 1583 |
|
|
2021
Q4 | – | Sell |
-3,406
| Closed | -$706K | – | 2270 |
|
|
2021
Q3 | $706K | Buy |
+3,406
| New | +$751K | ﹤0.01% | 1351 |
|
|
2021
Q2 | – | Sell |
-14,100
| Closed | -$2.56M | – | 2360 |
|
|
2021
Q1 | $2.56M | Buy |
14,100
+2,200
| +18% | +$438K | 0.01% | 627 |
|
|
2020
Q4 | $1.33M | Buy |
11,900
+500
| +4% | +$53.1K | 0.01% | 901 |
|
|
2020
Q3 | $1.24M | Buy |
11,400
+3,000
| +36% | +$365K | 0.01% | 824 |
|
|
2020
Q2 | $700K | Buy |
+8,400
| New | +$321K | ﹤0.01% | 1085 |
|
|
2016
Q3 | – | Sell |
-420
| Closed | -$54.2K | – | 1939 |
|
|
2016
Q2 | $61K | Hold |
420
| – | – | ﹤0.01% | 1741 |
|
|
2016
Q1 | $43K | Sell |
420
-6,215
| -94% | -$667K | ﹤0.01% | 1781 |
|
|
2015
Q4 | $1.11M | Sell |
6,635
-915
| -12% | -$141K | 0.01% | 759 |
|
|
2015
Q3 | $1.07M | Buy |
7,550
+120
| +2% | +$26.9K | 0.01% | 791 |
|
|
2015
Q2 | $1.66M | Sell |
7,430
-290
| -4% | -$51K | 0.01% | 664 |
|
|
2015
Q1 | $1.28M | Sell |
7,720
-1,545
| -17% | -$251K | 0.01% | 696 |
|
|
2014
Q4 | $1.1M | Hold |
9,265
| – | – | ﹤0.01% | 749 |
|
|
2014
Q3 | $773K | Sell |
9,265
-405
| -4% | -$36.6K | ﹤0.01% | 888 |
|
|
2014
Q2 | $894K | Buy |
9,670
+875
| +10% | +$76.9K | ﹤0.01% | 848 |
|
|
2014
Q1 | $797K | Buy |
8,795
+180
| +2% | +$20.1K | ﹤0.01% | 868 |
|
|
2013
Q4 | $882K | Sell |
8,615
-995
| -10% | -$70.3K | ﹤0.01% | 832 |
|
|
2013
Q3 | $607K | Buy |
+9,610
| New | +$541K | ﹤0.01% | 1141 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
STRS Ohio's NVAX Position: Q1 2026 in Review
STRS Ohio reduced its Novavax (NVAX) stake by 30% in Q1 2026, selling an estimated $285K and leaving 74,600 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #942.
STRS Ohio first reported a position in NVAX in Q3 2013 and has held it in 30 quarters since. The position peaked at $2.56M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- STRS Ohio held 74,600 shares of Novavax worth $607K as of Q1 2026.
- STRS Ohio sold 31,400 Novavax shares in Q1 2026, an estimated $285K.
- Novavax made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #942 holding.
- STRS Ohio first reported a position in Novavax in Q3 2013 and has held it in 30 quarters since.
- STRS Ohio's Novavax position peaked at $2.56M in Q1 2021.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.